VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance

U.S. Markets closed

Vertex Pharmaceuticals Incorpor (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
116.70-0.56 (-0.48%)
At close: 4:00PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close117.26
Bid72.00 x 100
Ask116.75 x 100
Day's Range115.92 - 117.69
52 Week Range71.46 - 117.99
Avg. Volume1,864,092
Market Cap28.99B
PE Ratio (TTM)-253.70
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 3 Stocks That Growth Investors Should Love
    Motley Fool4 hours ago

    3 Stocks That Growth Investors Should Love

    Impressive growth could be in store for biotech stocks Celgene, Ionis, and Vertex.

  • American City Business Journals2 days ago

    Trump invites ​Vertex CEO to White House for biotech summit

    Vertex Pharmaceuticals CEO Jeffrey Leiden is among a group of pharmaceutical executives that have reportedly been invited to meet with top officials from the Trump Administration next month to discuss issues facing the industry — a sign of the Boston drugmaker’s growing clout. The planned May 8 meeting at the White House was reported by Bloomberg News on Friday afternoon . A spokesperson for Vertex (VRTX), one of the largest drug companies based in Massachusetts, confirmed that Leiden has been invited to the summit, but declined to say whether he will attend.

  • American City Business Journals5 days ago

    ​Vertex at odds with religious investors over lobbying disclosures

    Two religious organizations that own shares of Vertex Pharmaceuticals are pushing the Boston drugmaker to disclose more information about its lobbying on drug pricing and other hot-button issues, an effort that the company opposes. Vertex (VRTX) said in a federal filing Monday that it will ask shareholders to reject the measure during its annual meeting in June. The measure would require Vertex to disclose how much it spends on lobbying at the local, state and federal levels, including payments it makes to trade groups and spending on “grassroots” communications that seek to shape public opinion on policy issues.